U.S. markets closed
  • S&P Futures

    4,368.25
    +7.25 (+0.17%)
     
  • Dow Futures

    34,276.00
    +44.00 (+0.13%)
     
  • Nasdaq Futures

    14,904.25
    +34.75 (+0.23%)
     
  • Russell 2000 Futures

    1,798.80
    +6.10 (+0.34%)
     
  • Crude Oil

    90.44
    +0.41 (+0.46%)
     
  • Gold

    1,945.20
    -0.40 (-0.02%)
     
  • Silver

    23.85
    +0.01 (+0.05%)
     
  • EUR/USD

    1.0652
    -0.0010 (-0.10%)
     
  • 10-Yr Bond

    4.4380
    -0.0420 (-0.94%)
     
  • Vix

    17.20
    -0.34 (-1.94%)
     
  • GBP/USD

    1.2247
    -0.0047 (-0.38%)
     
  • USD/JPY

    148.3510
    +0.7880 (+0.53%)
     
  • Bitcoin USD

    26,501.87
    -76.26 (-0.29%)
     
  • CMC Crypto 200

    565.87
    -2.18 (-0.38%)
     
  • FTSE 100

    7,683.91
    +5.29 (+0.07%)
     
  • Nikkei 225

    32,402.41
    -168.59 (-0.52%)
     

Abbott hepatitis C genotyping test approved by FDA

The FDA announced the approval of a test that identifies the genotype of hepatitis C virus that apatientis carrying. The Abbott RealTime HCV Genotype II, which can differentiate genotypes 1, 1a, 1b, 2, 3, 4, and 5, using a sample of an infected patient’s blood plasma or serum, will aid health care professionals in determining the appropriate approach to treatment, the FDA added.